Bozor qiymatining balans qiymatiga nisbati: aclaristx.com (ACRS)
Aclaris Therapeutics (ACRS) hozirda ichki rezervlar va xarajatlarni kamaytirishga tayanmoqda, chunki uning asosiy ishlanmalari sinov bosqichida qolmoqda. Patent litsenziyalash strategiyasi risklarni minimallashtiradi va kelajakdagi pul oqimi uchun asos yaratadi, u hozirda 4.42 miqdorini tashkil etadi. Aksiyalar narxi dinamikasining ushbu grafigi aksiyaning klinik sinovlar natijalariga va global sog'liqni saqlash gigantlarining qiziqishiga bog'liqligini ko'rsatadi.
Aclaris Therapeutics Inc. (ACRS) - koʻrsatkichlar kesimi va moliyaviy hisobotlar
- bozor qiymati va tahlilchilarning maqsadli prognozi:
- kompaniyaning birjadagi kapitallashuv ko'rsatkichlari:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz majburiyatlari va likvidlik statistikasi:
Qarzning xususiy kapitalga nisbati Aclaris Therapeutics|ACRS - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati Aclaris|ACRS - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Aclaris|ACRS - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli majburiyatlari Aclaris Therapeutics|Tezkor likvidlik koeffitsiyenti aclaristx.com
- foyda va baholash multiplikatorlari ko'rsatkichlari:
Kompaniyaning asosiy tahlili:Aclaris Therapeutics - ACRS
Aclaris Therapeutics (ACRS) moliyaviy barqarorligini baholayotgan investor kelajakdagi o'sish uchun premiumni aniqlash maqsadida ushbu ko'rsatkichdan barcha aksiyalarning umumiy bozor qiymatining kompaniyaning sof kapitaliga nisbati sifatida foydalanadi. Bozor kapitalizatsiyasining kitob kapitalizatsiyasiga nisbati o'zgarishini tahlil qilish orqali, klinik sinovlar uchun chuqur autsorsing modelining kapital xarajatlarini qanday minimallashtirishi va intellektual mulkning yuqori bozor baholash sharoitida aktivlar balansini qanday saqlab qolishi ko'rinadi.
Raqobatchilar tahlili
argenx SE (ARGX) - Bozor qiymatining balans qiymatiga nisbati|BNTX - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati abivax.com|ADMA Biologics Inc - Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati PTGX|IMVT (Immunovant Therapeutics) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati KNSA (Kiniksa Pharmaceuticals)|Bozor kapitallashuvining balans qiymatiga nisbati grifols.com GRFS|ADPT - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati CLDX (Celldex Therapeutics Inc)|Aurinia Pharma (AUPH) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati BioCryst Corp|VERA (Vera Therapeutics, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati dianthustx.com|Kapitallashuvning sof aktivlarga nisbati PHVS (Pharvaris)|ABCL (AbCellera Biologics) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati TRML (Tourmaline Corp)|Balans qiymatiga nisbatan bozor kapitallashuvi Precigen Corp (PGEN)|PHAR - Bozor qiymatining balans qiymatiga nisbati|nektar.com (NKTR) - Kapitallashuvning sof aktivlarga nisbati|Upstream Bio (UPB) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Zenas Bio|Kapitallashuvning sof aktivlarga nisbati IMNM|Bozor kapitallashuvining balans qiymatiga nisbati Gossamer Bio Corp.|Bozor qiymatining balans qiymatiga nisbati KalVista Pharmaceuticals (KALV)|septerna.com - Kapitallashuvning balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati PVLA (Pieris Pharmaceuticals, Inc.)|Savara Inc (SVRA) - Bozor qiymatining balans qiymatiga koeffitsiyenti|Rigel Pharmaceuticals Inc - Bozor kapitallashuvining balans qiymatiga nisbati|ANAB - Bozor kapitallashuvining balans qiymatiga nisbati|ATXS: Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati engene.com|Bozor qiymatining balans qiymatiga nisbati RAPT Therapeutics|Bozor qiymatining balans qiymatiga nisbati JBIO|Bozor kapitallashuvining balans qiymatiga nisbati KYTX|Bozor kapitallashuvining balans qiymatiga nisbati Tiziana Life Sciences, Ltd. (TLSA)|Bozor qiymatining balans qiymatiga nisbati Cabaletta Bio, Inc. CABA|Balans qiymatiga nisbatan bozor qiymati VTYX|Theratechnologies - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi Avalo Therapeutics, Inc. AVTX|Eledon (ELDN) - Bozor qiymatining balans qiymatiga nisbati|AGEN - Balans qiymatiga nisbatan bozor kapitallashuvi|Kapitallashuvning sof aktivlarga nisbati CLYM|ZURA: Balans qiymatiga nisbatan bozor qiymati|Kapitallashuvning sof aktivlarga nisbati ATYR (aTyr Pharma)|Bozor kapitallashuvining balans qiymatiga multiplikatori ADAG|Bozor kapitallashuvining balans qiymatiga nisbati IMA (Ikena Oncology)|Balans qiymatiga nisbatan bozor qiymati STTK|Equillium Bio - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Connect Biopharma|immunic-therapeutics.com (IMUX) - Bozor qiymatining balans qiymatiga nisbati|Atara Bio - Balans qiymatiga nisbatan bozor qiymati|IFRX (InflaRx NV) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati X4 Pharmaceuticals, Inc|Bozor qiymatining balans qiymatiga nisbati Adicet Bio (ACET)|CELU: Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati INMB (INmune Bio)|Barinthus Biotherapeutics PLC (BRNS) - Bozor qiymatining balans qiymatiga koeffitsiyenti|KZR: Kapitallashuvning sof aktivlarga nisbati|SABS - Bozor kapitallashuvining balans qiymatiga nisbati|AKTX (Akari Therapeutics) - Kapitallashuvning sof aktivlarga nisbati|ENLV: Bozor kapitallashuvining balans qiymatiga multiplikatori|QTTB (Q32 Bio Inc) - Bozor kapitallashuvining balans qiymatiga nisbati|GeoVax Labs (GOVX) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati EDSA|Kapitallashuvning sof aktivlarga nisbati iBio Corporation IBIO|Bozor qiymatining balans qiymatiga nisbati Carisma Therapeutics Inc. CARM|Balans qiymatiga nisbatan bozor kapitallashuvi xtlbio.com (XTLB)|Bolt Bio - Bozor kapitallashuvining balans qiymatiga nisbati|HCWB - Bozor kapitallashuvining balans qiymatiga nisbati|APVO: Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati aimimmuno.com|Bozor qiymatining balans qiymatiga nisbati Aditxt Inc.|GRI: Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati XORTX Therapeutics (XRTX)|Balans qiymatiga nisbatan bozor kapitallashuvi Vyome Holdings Inc.|Bozor qiymatining balans qiymatiga nisbati Revelation Bio REVB|INDP (Indaptus Corp) - Sof aktivlarga nisbatan bozor kapitallashuvi|Scinai Immunotherapeutics - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati CALI (CalciMedica, Inc.)|AFMD: Bozor kapitallashuvining balans qiymatiga nisbati|Allakos (ALLK) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga nisbati HOOKIPA Pharma, Inc.|IGMS: Balans qiymatiga nisbatan bozor qiymati|Bozor qiymatining balans qiymatiga nisbati iTeos Therapeutics (ITOS)|Kapitallashuvning sof aktivlarga nisbati oceanbiomedical.com OCEA|Bozor kapitallashuvining balans qiymatiga nisbati TCBP (TC BioPharm)|Bozor kapitallashuvining balans qiymatiga nisbati Third Harmonic Bio Inc. THRD